Posts

Rottweiler puppy uses CBD

CBD for Puppy Growing Pains

Titan’s upside down puppy grin says it all. He gives ABSC Pure Organic CBD Oil™ two paws up!

Dr. Stephanie McGrath

Dr. Stephanie McGrath Addresses CSU Pueblo

Assessment of Safety, Toxicity, and Pharmacokinetics of Cannabidiol in Healthy Dogs

Have you ever wanted to know more about ABSC and how we came to be involved with clinical trials at CSU? We’re pulling a video out of the archives today to share with you! This short video of Veterinary Neurologist Dr. Stephanie McGrath speaking at a conference at CSU Pueblo in 2017 highlights her work on safety, toxicity, and pharmacokinetics of CBD. During her talk, Dr. McGrath discusses her interest in testing CBD for dogs and her concerns with unregulated and untested CBD products. She needed a safe and pure product to run trials with, and ABSC wanted to support advanced research in the field. It was a match made in heaven, and the rest is history!

McGrath Presentation (short) from Jadan Morrow on Vimeo.

CB1 Receptor Chart

The Endocannabinoid System Explained

Introducing our CBD Literacy video education series

Ever wondered about the science behind CBD and its effects on your dog’s body? We know that many of our furry companions who use C.H.O.™ CBD Oil get relief from pain, anxiety, seizures and more. But you may have wondered, “how and why does CBD work?”

Our friend and colleague Sam Stewart, DVM, from Ethos Veterinary Health, has prepared this excellent video to explain the endocannibinoid system. This video is the first in a series–part of our effort to lead the way in veterinary CBD research and education. In this first video, you’ll gain a better understanding of how cannabinoids like CBD affect the brain and nervous system. About halfway through (10:22), Sam gives a great example of how CBD interrupts pain signals in the peripheral nervous system. And at minute 17, you’ll find a great explanation of how CBD binds to receptors and inhibits inflammation. The entire video provides a great overview–in layman’s terms–of the powerful endocannabinoid system.

At ABSC, we’re constantly working to improve and evolve science in the name of providing a better quality of life for our ailing companion animals. Want to learn more? Check out our News and Research Library! And subscribe to our YouTube channel–we’ve got more great educational content to come!

CBD Safetly Trial CSU

Groundbreaking Safety, Toxicity, and Pharmacokinetics Study Published

ABSC Sponsored Safety Study Published in the  Journal of the American Holistic Veterinary Medical Association

We are thrilled to announce that our Phase 1 Clinical Trial: Assessment of Safety, Toxicity, and Pharmacokinetics of Cannabidiol in Healthy Dogs has been successfully completed. Sponsored by ABSC Organics and conducted at Colorado State University’s College of Veterinary Medicine and Biomedical Sciences, the trial studied three different delivery mechanisms in 30 healthy beagles. With results appearing in the Fall 2018 issue of the Journal of the American Holistic Veterinary Medical Association, the study concluded that clinical doses of CBD were well tolerated by all the dogs in the study. This is groundbreaking news in the veterinary field, and represents a major step forward for CBD research and pet wellness.

St. Bernard in CBD Clinical Trial
Dr. Stephanie McGrath with Atticus, a 3-year-old Saint Bernard enrolled in a clinical trial of cannabidiol at Colorado State University’s Veterinary Teaching Hospital (Photo by John Eisele/Colorado State University Photography)

ABSC Organics–The Only Veterinary CBD Company With a Phase 1 Safety Trial

At ABSC we know that it’s easy to make claims, but more important to invest in the research to back up those claims. We care deeply about pets and their well-being. That’s why we’re so proud of the fact that ABSC Pure Organic CBD Oil is the only veterinary CBD product that has undergone a Phase 1 trial to assess safety and toxicity. This trial enables researchers to use our product in Phase 2 trials that will study CBD’s effects on epilepsy, arthritis, and more.